The prevalence is particularly high in patients with autosomal dominant CRD or MD; 12% in CRD/MD [17], 19.5% in autosomal dominant CRD/MD [18], and 10.3% in autosomal dominant RP were associated with PRPH2 [19], respectively. Here, PRPH2 is linked to cone-rod dystrophy.